Published in Hepat Mon on December 07, 2013
Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. World J Hepatol (2015) 0.80
The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. J Diabetes Metab Disord (2016) 0.78
Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. Int J Mol Sci (2015) 0.76
Egg consumption and risk of non-alcoholic fatty liver disease. World J Hepatol (2017) 0.75
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Adv Nutr (2017) 0.75
Ability of dairy fat in inducing metabolic syndrome in rats. Springerplus (2016) 0.75
Comments on "The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease". Hepat Mon (2016) 0.75
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology (2010) 8.05
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol (2008) 4.01
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem (2006) 3.57
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (2010) 3.55
A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol (2010) 3.53
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (2009) 2.92
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (2004) 2.77
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med (2011) 2.34
Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study. Bull World Health Organ (2007) 2.30
One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol (2005) 2.04
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr (2007) 1.99
An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol (2011) 1.98
Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc (2003) 1.87
A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes Surg (2011) 1.79
Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab (2002) 1.69
Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) (2008) 1.64
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem (2007) 1.62
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev (2004) 1.62
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol (2008) 1.59
The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta (2011) 1.57
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol (2011) 1.48
Nonalcoholic fatty liver disease. J Lipid Res (2008) 1.47
Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) (2009) 1.33
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol (2008) 1.33
Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm (2009) 1.26
Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology (2007) 1.26
Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol (2006) 1.21
Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol (2006) 1.16
Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon (2013) 1.09
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol (2009) 1.03
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition (2009) 1.03
Design and methods for testing a simple dietary message to improve weight loss and dietary quality. BMC Med Res Methodol (2009) 0.98
Therapy of nonalcoholic fatty liver disease: current status. J Physiol Pharmacol (2009) 0.93
Silent liver diseases in autopsies from forensic medicine of Tehran. Arch Iran Med (2006) 0.93
Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m². Nutr Res (2011) 0.91
Diet and nonalcoholic fatty liver disease. Curr Opin Lipidol (2008) 0.89
Way back for fructose and liver metabolism: bench side to molecular insights. World J Gastroenterol (2012) 0.87
Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD). J Nutr Sci Vitaminol (Tokyo) (2010) 0.86
Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation. Hepat Mon (2013) 0.86
The effects of weight loss on normal transaminase levels in obese patients. Am J Med Sci (2007) 0.81
Nutritional recommendations for patients with non-alcoholic fatty liver diseases. World J Gastroenterol (2011) 0.79